CVN766 is an orally active inhibitor of orexin 1 receptor antagonist with blood-brain permeability with the IC 50 values of 8 nM and >10 μM for OX1R and OX2R , respectively. CVN766 can be used for study schizophrenia.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Orexin Receptor (OX Receptor)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.